1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?
No
1e. Today's Date
1f. Name of standard being reaffirmed
1g. Project Artifact Information
1h. ISO/IEC Standard to Adopt
1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?
1j. Unit of Measure
2a. Primary/Sponsor WG
Pharmacy
2d. Project Facilitator
Scott Robertson
2e. Other Interested Parties (and roles)
NCPDP MTM&PCS Work Group
2f. Modeling Facilitator
2g. Publishing Facilitator
Margaret Weiker (NCPDP)
2h. Vocabulary Facilitator
2i. Domain Expert Representative
2j. Business Requirements Analyst
2k. Conformance Facilitator
Scott Robertson
2l. Other Facilitators
2m. Implementers
3a. Project Scope
The MTM Encounter supporting documentation templates will be based on the HL7 Implementation Guide for FHIR: Designed to provide a vehicle for reporting the results from a Medication Therapy Management (MTM) Comprehensive Medication Review (CMR). MTM Services (e.g., Clinical Documentation, Medication Therapy Outcomes), and the patient-specific Personal Medication Action Plan and Medication List.
Attachments
3b. Project Need
This project will support the documentation and communication needs of the expanding MTM services arena as well as support the CMS Medicare Part D reporting and patient information requirements for MTM.
3c. Security Risk
No
3d. External Drivers
CMS Medicare Part D program is in the process of revising the CMR summary regulatory requirements.
3e. Objectives/Deliverables and Target Dates
Completion of CMR Summary FHIR IG January 2022 Ballot
Project End Date January 2023 WGM
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Process Improvement Committee
2d. Project Facilitator
Scott Robertson
2e. Other Interested Parties (and roles)
NCPDP MTM&PCS Work Group
2g. Publishing Facilitator
Margaret Weiker (NCPDP)
2k. Conformance Facilitator
Scott Robertson
3a. Project Scope
The MTM Encounter supporting documentation templates will be based on the HL7 Implementation Guide for FHIR: Designed to provide a vehicle for reporting the results from a Medication Therapy Management (MTM) Comprehensive Medication Review (CMR). MTM Services (e.g., Clinical Documentation, Medication Therapy Outcomes), and the patient-specific Personal Medication Action Plan and Medication List.
3b. Project Need
This project will support the documentation and communication needs of the expanding MTM services arena as well as support the CMS Medicare Part D reporting and patient information requirements for MTM.
3c. Security Risk
No
3d. External Drivers
CMS Medicare Part D program is in the process of revising the CMR summary regulatory requirements.
3e. Objectives/Deliverables and Target Dates
Completion of CMR Summary FHIR IG January 2022 Ballot
Project End Date January 2023 WGM
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Process Improvement Committee
2d. Project Facilitator
Scott Robertson
2e. Other Interested Parties (and roles)
NCPDP MTM&PCS Work Group
2g. Publishing Facilitator
Margaret Weiker (NCPDP)
2k. Conformance Facilitator
Scott Robertson
3a. Project Scope
The MTM Encounter supporting documentation templates will be based on the HL7 Implementation Guide for FHIR: Designed to provide a vehicle for reporting the results from a Medication Therapy Management (MTM) Comprehensive Medication Review (CMR). MTM Services (e.g., Clinical Documentation, Medication Therapy Outcomes), and the patient-specific Personal Medication Action Plan and Medication List.
3b. Project Need
This project will support the documentation and communication needs of the expanding MTM services arena as well as support the CMS Medicare Part D reporting and patient information requirements for MTM.
3c. Security Risk
No
3d. External Drivers
CMS Medicare Part D program is in the process of revising the CMR summary regulatory requirements.
3e. Objectives/Deliverables and Target Dates
Completion of CMR Summary FHIR IG January 2022 Ballot
Project End Date January 2023 WGM
